Q3 2020 Aerpio Pharmaceuticals Inc Earnings Call Transcript
Greetings. Welcome to the Aerpio Pharmaceuticals Third Quarter 2020 Earnings Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Gina Marek, Vice President of Finance. You may begin.
Good morning. Thank you for joining us for Aerpio's Third Quarter 2020 Earnings Call. Joining me on the call today from Aerpio is Joseph Gardner, President and Founder; and Kevin Peters, Chief Science and Medical Officer. This morning, Aerpio released financial results for the third quarter ended September 30, 2020. If you have not received the news release or if you would like to be added to the company's distribution list, you can do so on the Investor Relations page of our website at aerpio.com.
I'd also like to remind you the remarks made on the call today include forward-looking statements about Aerpio. Such statements may include, but are not limited to, those related to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |